Literature DB >> 27376795

High risk factors of pancreatic carcinoma.

Soriba Naby Camara1, Tao Yin1, Ming Yang1, Xiang Li1, Qiong Gong1, Jing Zhou2, Gang Zhao1, Zhi-Yong Yang1, Tajoo Aroun1, Martin Kuete3, Sonam Ramdany4, Alpha Kabinet Camara5, Aissatou Taran Diallo6, Zhen Feng7, Xin Ning8, Jiong-Xin Xiong1, Jing Tao1, Qi Qin1, Wei Zhou1, Jing Cui1, Min Huang1, Yao Guo1, Shan-Miao Gou1, Bo Wang1, Tao Liu1, Ohoya Etsaka Terence Olivier1, Tenin Conde5, Mohamed Cisse9, Aboubacar Sidiki Magassouba5, Sneha Ballah10, Naby Laye Moussa Keita11, Ibrahima Sory Souare12, Aboubacar Toure6, Sadamoudou Traore13, Abdoulaye Korse Balde14, Namory Keita15, Naby Daouda Camara6, Dusabe Emmanuel16, He-Shui Wu1, Chun-You Wang17.   

Abstract

Over the past decades, cancer has become one of the toughest challenges for health professionals. The epidemiologists are increasingly directing their research efforts on various malignant tumor worldwide. Of note, incidence of cancers is on the rise more quickly in developed countries. Indeed, great endeavors have to be made in the control of the life-threatening disease. As we know it, pancreatic cancer (PC) is a malignant disease with the worst prognosis. While little is known about the etiology of the PC and measures to prevent the condition, so far, a number of risk factors have been identified. Genetic factors, pre-malignant lesions, predisposing diseases and exogenous factors have been found to be linked to PC. Genetic susceptibility was observed in 10% of PC cases, including inherited PC syndromes and familial PC. However, in the remaining 90%, their PC might be caused by genetic factors in combination with environmental factors. Nonetheless, the exact mechanism of the two kinds of factors, endogenous and exogenous, working together to cause PC remains poorly understood. The fact that most pancreatic neoplasms are diagnosed at an incurable stage of the disease highlights the need to identify risk factors and to understand their contribution to carcinogenesis. This article reviews the high risk factors contributing to the development of PC, to provide information for clinicians and epidemiologists.

Entities:  

Keywords:  epidemiology; etiology; high risk factors; pancreatic cancer; pathogenesis; treatment

Mesh:

Substances:

Year:  2016        PMID: 27376795     DOI: 10.1007/s11596-016-1583-x

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  152 in total

1.  Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study.

Authors:  Anne C M Thiébaut; Li Jiao; Debra T Silverman; Amanda J Cross; Frances E Thompson; Amy F Subar; Albert R Hollenbeck; Arthur Schatzkin; Rachael Z Stolzenberg-Solomon
Journal:  J Natl Cancer Inst       Date:  2009-06-26       Impact factor: 13.506

2.  Etiology, pathology, management and prognosis of chronic pancreatitis in Chinese population: A retrospective study.

Authors:  Soriba Naby Camara; Sonam Ramdany; Gang Zhao; Shan-Miao Gou; Jiong-Xin Xiong; Zhi-Yong Yang; Tao Yin; Ming Yang; Oumar Taibata Balde; Ahmed Boubacar Barry; Seid Adji; Xiang Li; Yan Jin; He-Shui Wu; Chun-You Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

3.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

4.  High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.

Authors:  A Borg; T Sandberg; K Nilsson; O Johannsson; M Klinker; A Måsbäck; J Westerdahl; H Olsson; C Ingvar
Journal:  J Natl Cancer Inst       Date:  2000-08-02       Impact factor: 13.506

5.  Past medical history and pancreatic cancer risk: Results from a multicenter case-control study.

Authors:  Patrick Maisonneuve; Albert B Lowenfels; H Bas Bueno-de-Mesquita; Parviz Ghadirian; Peter A Baghurst; Witold A Zatonski; Anthony B Miller; Eric J Duell; Paolo Boffetta; Peter Boyle
Journal:  Ann Epidemiol       Date:  2010-02       Impact factor: 3.797

6.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

Review 7.  Tropical chronic pancreatitis.

Authors:  K K Barman; G Premalatha; V Mohan
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

Review 8.  Ataxia-telangiectasia: an overview.

Authors:  E Boder
Journal:  Kroc Found Ser       Date:  1985

9.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

10.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

Authors:  J Everhart; D Wright
Journal:  JAMA       Date:  1995 May 24-31       Impact factor: 56.272

View more
  5 in total

1.  Magnetic resonance elastography of the pancreas: Measurement reproducibility and relationship with age.

Authors:  Arunark Kolipaka; Samuel Schroeder; Xiaokui Mo; Zarine Shah; Phil A Hart; Darwin L Conwell
Journal:  Magn Reson Imaging       Date:  2017-05-02       Impact factor: 2.546

2.  Pancreatic cystic lesions in diabetes mellitus patients.

Authors:  Martyna Rozek; Michal Lipinski; Ewa Jozefik; Zuzanna Znajdek; Marta Kiziak; Marta Sznurkowska; Jacek Tatur; Malgorzata Degowska; Grazyna Rydzewska
Journal:  Prz Gastroenterol       Date:  2020-06-04

3.  Identification of Prognostic Immune-Related Genes in Pancreatic Adenocarcinoma and Establishment of a Prognostic Nomogram: A Bioinformatic Study.

Authors:  Guolin Wu; Zhenfeng Deng; Zongrui Jin; Jilong Wang; Banghao Xu; Jingjing Zeng; Minhao Peng; Zhang Wen; Ya Guo
Journal:  Biomed Res Int       Date:  2020-06-09       Impact factor: 3.411

4.  TMEFF2 inhibits pancreatic cancer cells proliferation, migration, and invasion by suppressing phosphorylation of the MAPK signaling pathway.

Authors:  Hongchao Han; Zhilin Zhan; Jie Xu; Zhenshun Song
Journal:  Onco Targets Ther       Date:  2019-12-23       Impact factor: 4.147

5.  Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease.

Authors:  Deirdré Kruger; Nicola Lahoud; Yandiswa Y Yako; John Devar; Martin Smith
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.